The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 29, 2026

Filed:

Jun. 27, 2022
Applicants:

Northwestern University, Evanston, IL (US);

The George Washington University, Washington, DC (US);

Inventors:

John A. Rogers, Wilmette, IL (US);

Yeonsik Choi, Evanston, IL (US);

Igor Efimov, Washington, DC (US);

Rose T. Yin, Washington, DC (US);

Assignees:

NORTHWESTERN UNIVERSITY, Evanston, IL (US);

THE GEORGE WASHINGTON UNIVERSITY, Washington, DC (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61N 1/375 (2006.01); A61L 31/10 (2006.01); A61L 31/14 (2006.01); A61N 1/02 (2006.01); A61N 1/05 (2006.01); A61N 1/362 (2006.01); A61N 1/372 (2006.01); A61N 1/378 (2006.01); A61N 1/39 (2006.01); A61L 31/02 (2006.01);
U.S. Cl.
CPC ...
A61N 1/37229 (2013.01); A61L 31/10 (2013.01); A61L 31/148 (2013.01); A61N 1/025 (2013.01); A61N 1/059 (2013.01); A61N 1/0595 (2013.01); A61N 1/362 (2013.01); A61N 1/37512 (2017.08); A61N 1/3756 (2013.01); A61N 1/3758 (2013.01); A61N 1/3787 (2013.01); A61N 1/39622 (2017.08); A61L 31/022 (2013.01);
Abstract

A device implantable on a target of interest of a subject for pacemaker, neuromodulator, and/or defibrillator therapy comprises a wireless power harvesting unit configured to deliver power via resonant inductive coupling to the target tissue for stimulation in a manner that eliminates need for batteries and allows for externalized control without transcutaneous leads. The device relies exclusively on materials that resorb when exposed to biofluids in a time-controlled manner via metabolic action and hydrolysis. The materials and design choices create a thin, flexible, and lightweight form that maintain excellent biocompatibility and stable function throughout a desired period of use. Over a subsequent timeframe following the completion of therapy, the devices disappear completely through natural biological processes. These characteristics and a miniaturized geometry facilitate full implantation into the body to eliminate the need for percutaneous hardware, which thereby minimizes the risk of device-associated infections and dislodgement.


Find Patent Forward Citations

Rogers, John. (2026). Bioresorbable cardiovascular instruments, and operation and fabrication methods of same (U.S. Patent No. 12746397). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12746397

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…